Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.

Tan KK, Pal S, Lee PJ, Rodwell L, Solomon MJ.

Colorectal Dis. 2013;15(10):1227-31. doi: 10.1111/codi.12306.

PMID:
23714581
2.

Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.

Milne T, Solomon MJ, Lee P, Young JM, Stalley P, Harrison JD, Austin KK.

Dis Colon Rectum. 2014 Oct;57(10):1153-61. doi: 10.1097/DCR.0000000000000196.

PMID:
25203370
3.

Total pelvic exenteration for primary and recurrent malignancies.

Ferenschild FT, Vermaas M, Verhoef C, Ansink AC, Kirkels WJ, Eggermont AM, de Wilt JH.

World J Surg. 2009 Jul;33(7):1502-8. doi: 10.1007/s00268-009-0066-7.

4.

[Pelvic exenterations for gynaecological cancer--a 10 year institutional review].

Pinelo S, Petiz A, Domingues C, Lopes C, Alves A, Fael R.

Acta Med Port. 2006 Mar-Apr;19(2):99-104. Epub 2006 Aug 18. Portuguese.

5.

Does histologic type correlate to outcome after pelvic exenteration for cervical and vaginal cancer?

Baiocchi G, Guimaraes GC, Faloppa CC, Kumagai LY, Oliveira RA, Begnami MD, Soares FA, Lopes A.

Ann Surg Oncol. 2013 May;20(5):1694-700. doi: 10.1245/s10434-012-2768-6. Epub 2012 Dec 5.

PMID:
23212765
6.

Pelvic exenteration for adenocarcinoma of the uterine cervix.

Crozier M, Morris M, Levenback C, Lucas KR, Atkinson EN, Wharton JT.

Gynecol Oncol. 1995 Jul;58(1):74-8.

PMID:
7789894
7.

Pelvic Exenteration in Gynecologic Cancer: La Paz University Hospital Experience.

Moreno-Palacios E, Diestro MD, De Santiago J, Hernández A, Zapardiel I.

Int J Gynecol Cancer. 2015 Jul;25(6):1109-14. doi: 10.1097/IGC.0000000000000435.

PMID:
25853383
8.

(Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy.

Höckel M, Horn LC, Einenkel J.

Gynecol Oncol. 2012 Nov;127(2):297-302. doi: 10.1016/j.ygyno.2012.07.120. Epub 2012 Aug 1.

PMID:
22864112
9.

Pelvic exenteration: long-term oncological results in a series of 106 patients.

De Wever I.

Acta Chir Belg. 2011 Sep-Oct;111(5):282-7.

PMID:
22191128
10.

A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration.

Husain A, Akhurst T, Larson S, Alektiar K, Barakat RR, Chi DS.

Gynecol Oncol. 2007 Jul;106(1):177-80. Epub 2007 May 2.

PMID:
17477959
11.

Pelvic exenteration, University of Michigan: 100 patients at 5 years.

Morley GW, Hopkins MP, Lindenauer SM, Roberts JA.

Obstet Gynecol. 1989 Dec;74(6):934-43.

PMID:
2586960
12.

Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.

Jäger L, Nilsson PJ, Rådestad AF.

Int J Gynecol Cancer. 2013 May;23(4):755-62. doi: 10.1097/IGC.0b013e318287a874. Review.

PMID:
23407096
13.

Surgical salvage of recurrent rectal cancer after transanal excision.

Weiser MR, Landmann RG, Wong WD, Shia J, Guillem JG, Temple LK, Minsky BD, Cohen AM, Paty PB.

Dis Colon Rectum. 2005 Jun;48(6):1169-75.

PMID:
15793645
14.

Surgery and high-dose-rate intraoperative radiation therapy for recurrent squamous-cell carcinoma of the anal canal.

Wright JL, Gollub MJ, Weiser MR, Saltz LB, Wong WD, Paty PB, Temple LK, Guillem JG, Minsky BD, Goodman KA.

Dis Colon Rectum. 2011 Sep;54(9):1090-7. doi: 10.1097/DCR.0b013e318220c0a1.

PMID:
21825888
15.

Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome.

Andikyan V, Khoury-Collado F, Gerst SR, Talukdar S, Bochner BH, Sandhu JS, Abu-Rustum N, Sonoda Y, Barakat RR, Chi DS.

Gynecol Oncol. 2012 Sep;126(3):346-50. doi: 10.1016/j.ygyno.2012.04.034. Epub 2012 Apr 30.

PMID:
22555107
16.

Pelvic exenterations for gynecological malignancies: a study of 36 cases.

Kaur M, Joniau S, D'Hoore A, Van Calster B, Van Limbergen E, Leunen K, Penninckx F, Van Poppel H, Amant F, Vergote I.

Int J Gynecol Cancer. 2012 Jun;22(5):889-96. doi: 10.1097/IGC.0b013e31824eb8cd.

PMID:
22617477
17.

Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.

Fleisch MC, Pantke P, Beckmann MW, Schnuerch HG, Ackermann R, Grimm MO, Bender HG, Dall P.

J Surg Oncol. 2007 May 1;95(6):476-84.

PMID:
17192947
18.

Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.

Sardain H, Lavoué V, Laviolle B, Henno S, Foucher F, Levêque J.

Int J Gynecol Cancer. 2014 Nov;24(9):1679-85. doi: 10.1097/IGC.0000000000000288.

PMID:
25254565
19.

Pelvic exenteration. Has it a role in 1987? A six year experience.

Shepherd JH.

Verh K Acad Geneeskd Belg. 1989;51(1):31-44; discussion 44-6.

PMID:
2800684
20.

[The role of radical surgery in the treatment of epidermoid carcinoma of the anal canal].

Luna-Pérez P, Fernández A, Labastida S, Acevedo C, Torres S, Padilla R, Herrera Ornelas L.

Gac Med Mex. 1994 Sep-Oct;130(5):380-5. Spanish.

PMID:
7607369
Items per page

Supplemental Content

Write to the Help Desk